drugset
drugset / Trial / NCT01394627

Hypoglycemia and the Mineralocorticoid Receptor

NCT01394627 ↗

Completed 21 enrolled Brigham and Women's Hospital National Heart, Lung, and Blood Institute (NHLBI) · collabNational Institutes of Health (NIH) · collabRobert Wood Johnson Foundation · collab
RandomizedCrossoverDouble-blindBasic science

Summary

The purpose of this study is to look at whether blockade of the mineralocorticoid receptor will result in changes in the cardiovascular and inflammatory response to hypoglycemia.

Timeline

Start
2011-01
Primary completion
2016-08
Completion
2016-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Eplerenone Unknown 100 mg —

Indications

hypoglycemia